RAPHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Raphael Pharmaceutical Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.51+0.11 (+7.86%)
Close on Oct 16, 2026
- Market cap
- $30.47M
- P/E (TTM)
- 75.5
- Dividend yield
- –
Community
Notes and questions about Raphael Pharmaceutical from other investors
No posts about RAPH yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.